Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
Jun Zhou, Maoyi Li, Qiufang Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 351

Showing 1-25 of 351 citing articles:

Probiotics Mechanism of Action on Immune Cells and Beneficial Effects on Human Health
Chiara Mazziotta, Mauro Tognon, Fernanda Martini, et al.
Cells (2023) Vol. 12, Iss. 1, pp. 184-184
Open Access | Times Cited: 351
Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
Supriya Roy, Suneela Dhaneshwar
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2078-2100
Open Access | Times Cited: 136
Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases
Jun Liu, Yixin Wang, William J. Heelan, et al.
Science Advances (2022) Vol. 8, Iss. 45
Open Access | Times Cited: 124
Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: A comprehensive review
Eman M. Khalaf, Noor Adil Abood, Raghad Z. Atta, et al.
International Journal of Biological Macromolecules (2023) Vol. 231, pp. 123354-123354
Closed Access | Times Cited: 98
The Potential Impact of Probiotics on Human Health: An Update on Their Health-Promoting Properties
Nicoleta-Maricica Maftei, Cosmin Raducu Raileanu, Alexia Anastasia Stefania Balta, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 234-234
Open Access | Times Cited: 97
Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease
Yuji Pu, Fan Xi, Zhuangzhuang Zhang, et al.
Journal of Controlled Release (2022) Vol. 354, pp. 1-18
Closed Access | Times Cited: 75
Oral polyphenol-armored nanomedicine for targeted modulation of gut microbiota–brain interactions in colitis
Huan He, Qiaozhen Qin, Fang Xu, et al.
Science Advances (2023) Vol. 9, Iss. 21
Open Access | Times Cited: 69
IBD disease-modifying therapies: insights from emerging therapeutics
Niranjan G. Kotla, Yury Rochev
Trends in Molecular Medicine (2023) Vol. 29, Iss. 3, pp. 241-253
Closed Access | Times Cited: 61
Modified Prebiotic-Based “Shield” Armed Probiotics with Enhanced Resistance of Gastrointestinal Stresses and Prolonged Intestinal Retention for Synergistic Alleviation of Colitis
Anqi Xie, Haihua Ji, Zheyi Liu, et al.
ACS Nano (2023) Vol. 17, Iss. 15, pp. 14775-14791
Closed Access | Times Cited: 58
An Orally-Administered Nanotherapeutics with Carbon Monoxide Supplying for Inflammatory Bowel Disease Therapy by Scavenging Oxidative Stress and Restoring Gut Immune Homeostasis
Xu Zhang, Zhang Yuan, Jianshuang Wu, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 21116-21133
Closed Access | Times Cited: 54
Engineered Living Materials for Advanced Diseases Therapy
Dong Xue, Wei Wu, Pei Pan, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 51
Biomaterials and Encapsulation Techniques for Probiotics: Current Status and Future Prospects in Biomedical Applications
Qiqi Sun, Sheng Yin, Yingxu He, et al.
Nanomaterials (2023) Vol. 13, Iss. 15, pp. 2185-2185
Open Access | Times Cited: 51
Reactive Oxygen Species‐Activated CO Versatile Nanomedicine with Innate Gut Immune and Microbiome Remodeling Effects for Treating Inflammatory Bowel Disease
Youyun Zeng, Mengni Fan, Qiang Zhou, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 49
Closed Access | Times Cited: 41
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 32
Chitosan-based nanofibrous scaffolds for biomedical and pharmaceutical applications: A comprehensive review
Yasir Q. Аlmajidi, Sivasankaran Ponnusankar, MVNL Chaitanya, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130683-130683
Closed Access | Times Cited: 29
Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis
Mairead K. Heavey, Anthony Hazelton, Yuyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 24
Intestinal Delivery of Probiotics: Materials, Strategies, and Applications
Chengcheng Li, Zi‐Xi Wang, Huining Xiao, et al.
Advanced Materials (2024) Vol. 36, Iss. 32
Closed Access | Times Cited: 20
Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease
Qinglian Hu, Jingyu Li, Tong Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12917-12932
Closed Access | Times Cited: 20
Advances in chitosan-based blends as potential drug delivery systems: A review
Mohamed J. Saadh, Chou‐Yi Hsu, Mohammed Ahmed Mustafa, et al.
International Journal of Biological Macromolecules (2024) Vol. 273, pp. 132916-132916
Closed Access | Times Cited: 18
Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis
Peilin Guo, Wenjing Wang, Qian Xiang, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 9, pp. 1502-1518.e9
Closed Access | Times Cited: 16
Role of Probiotics against Human Cancers, Inflammatory Diseases, and Other Complex Malignancies
Hammad Naeem, Hammad Ul Hassan, Muhammad Shahbaz, et al.
Journal of Food Biochemistry (2024) Vol. 2024, pp. 1-23
Open Access | Times Cited: 15
Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Navigating a challenging path: precision disease treatment with tailored oral nano-armor-probiotics
A. Chen, Ying Gong, S. C. Wu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Biomimetic Bacteriophage‐Like Particles Formed from Probiotic Extracts and NO Donors for Eradicating Multidrug‐Resistant Staphylococcus aureus
Caixin Gong, Guan Wei, Xiangmei Liu, et al.
Advanced Materials (2022) Vol. 34, Iss. 45
Closed Access | Times Cited: 52
Prodrug Integrated Envelope on Probiotics to Enhance Target Therapy for Ulcerative Colitis
Kun Zhang, Li Zhu, Yuan Zhong, et al.
Advanced Science (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top